Mengnuo Chen

I join the group of Rene Bernards in NKI as a postdoctoral fellow since September 2021.

Emerging evidence indicates the existence of drug tolerant persisters (DTPs) which survive targeted- or chemo- therapies through elusive non-mutational and reversible mechanisms. My project will mainly focus on investigating the vulnerabilities of those DTPs and how can these be exploited therapeutically.